No headlines found.
Globe Newswire (Tue, 8-Apr 8:57 AM ET)
Progyny Expands Maternal Health Support with Addition of Doula Services
Globe Newswire (Mon, 31-Mar 9:22 AM ET)
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
Globe Newswire (Tue, 11-Mar 9:03 AM ET)
Progyny, Inc. to Participate in Upcoming Investor Conferences
Globe Newswire (Fri, 7-Mar 2:00 PM ET)
Progyny, Inc. Announces Fourth Quarter 2024 Results
Globe Newswire (Thu, 27-Feb 4:01 PM ET)
Bruker Appoints Laura Francis to its Board of Directors
Business Wire (Fri, 21-Feb 8:00 AM ET)
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
Globe Newswire (Thu, 13-Feb 3:14 PM ET)
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
Globe Newswire (Mon, 10-Feb 5:41 PM ET)
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump
Globe Newswire (Tue, 28-Jan 8:44 AM ET)
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
Globe Newswire (Thu, 16-Jan 9:00 AM ET)
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Progyny trades on the NASDAQ stock market under the symbol PGNY.
As of April 9, 2025, PGNY stock price climbed to $22.56 with 1,706,382 million shares trading.
PGNY has a beta of 0.51, meaning it tends to be less sensitive to market movements. PGNY has a correlation of 0.02 to the broad based SPY ETF.
PGNY has a market cap of $1.92 billion. This is considered a Small Cap stock.
Last quarter Progyny reported $298 million in Revenue and $.42 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.05.
In the last 3 years, PGNY traded as high as $46.50 and as low as $13.39.
The top ETF exchange traded funds that PGNY belongs to (by Net Assets): IJR, VTI, VB, IWM, VXF.
PGNY has underperformed the market in the last year with a return of -37.1%, while SPY returned +7.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PGNY shares. However, PGNY has outperformed the market in the last 3 month and 2 week periods, returning +23.6% and +5.0%, while SPY returned -6.6% and -4.7%, respectively. This indicates PGNY has been having a stronger performance recently.
PGNY support price is $20.93 and resistance is $22.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGNY shares will trade within this expected range on the day.